Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study is for subjects with a diagnosis of bipolar disorder who have depression at the
time of recruitment. It involves brain imaging with an MRI (magnetic resonance imaging) and
PET scan (positron emission tomography) and treatment with an antidepressant. The medication
involves adding an SSRI (either celexa/citalopram or prozac/fluoxetine) to a mood stabilizer.